Author： Leenders K.L.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.12, Iss.6, 2002-12, pp. : 575-580
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New drug treatments in psychiatric disease
Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. :
Access to resources
Recommend
Drug Treatments in Development for Alzheimer's Disease
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 1, 2012-03 ,pp. :
Non-dopaminergic drug treatment of Parkinson’s disease
By Müller T.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. :
Parkinson's disease: prospects for improved drug therapy
By Hagan J.J. Middlemiss D.N. Sharpe P.C. Poste G.H.
Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. :